ImMage Biotherapeutics

Founded in May 2015, ImMAGE Biotherapeutics Corp. is a seed-funded biotechnology company developing the first universal Immunotherapy to treat patients with an aggressive form of breast cancer called Triple NegativeBreast Cancer (TNBC).

Website :

Call 2020

The 2020 Call for Application is now close. Stay tuned for the 2021 Call



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links